Health Care & Life Sciences » Pharmaceuticals | Sihuan Pharmaceutical Holdings Group Ltd.

Sihuan Pharmaceutical Holdings Group Ltd. | Ownership

Companies that own Sihuan Pharmaceutical Holdings Group Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
The Vanguard Group, Inc.
138,069,933
1.46%
670,000
0%
07/31/2018
BlackRock Fund Advisors
92,454,000
0.98%
0
0%
09/06/2018
Schroder Investment Management Ltd.
67,747,000
0.72%
-914,000
0.01%
07/31/2018
Dimensional Fund Advisors LP
61,796,000
0.65%
2,000
0%
04/30/2018
BlackRock Advisors (UK) Ltd.
46,435,000
0.49%
8,169,000
0%
09/06/2018
Norges Bank Investment Management
45,065,892
0.48%
13,376,795
0%
12/31/2017
Quoniam Asset Management GmbH
32,453,250
0.34%
11,148,000
0.18%
03/31/2018
Evli Fund Management Co. Ltd.
13,000,000
0.14%
13,000,000
0.06%
06/29/2018
Aberdeen Asset Investments Ltd.
12,755,000
0.14%
12,755,000
0.01%
11/30/2017
APG Asset Management NV
12,481,140
0.13%
12,481,140
0%
03/31/2018

About Sihuan Pharmaceutical Holdings Group

View Profile
Address
21/F, Building 2
Beijing Beijing 100025
China
Employees -
Website http://www.sihuanpharm.com
Updated 07/08/2019
Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. It focuses on the field of cardio-cerebral vascular system, nervous system, metabolism, anti-infective, and oncology. The company was founded by Feng Sheng Che and Wei Cheng Guo in 2001 and is headquartered in Beijing, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.